Norditropin FlexPro 15 mg/1.5 ml, solution for injection in pre-filled pen Ireland - English - HPRA (Health Products Regulatory Authority)

norditropin flexpro 15 mg/1.5 ml, solution for injection in pre-filled pen

novo nordisk a/s - somatropin - solution for injection in pre-filled pen - 15/1.5 milligram(s)/millilitre - somatropin and somatropin agonists; somatropin

Norditropin NordiFlex 15 mg/1.5 ml solution for injection in pre-filled pen Ireland - English - HPRA (Health Products Regulatory Authority)

norditropin nordiflex 15 mg/1.5 ml solution for injection in pre-filled pen

novo nordisk a/s - somatropin - solution for injection in pre-filled pen - 15mg/1.5ml micromole(s) - somatropin and somatropin agonists; somatropin

Norditropin NordiFlex 10 mg/1.5 ml solution for injection in pre-filled pen Ireland - English - HPRA (Health Products Regulatory Authority)

norditropin nordiflex 10 mg/1.5 ml solution for injection in pre-filled pen

novo nordisk a/s - somatropin - solution for injection in pre-filled pen - 10mg/1.5ml micromole(s) - somatropin and somatropin agonists; somatropin

Norditropin NordiFlex 5 mg/1.5 ml solution for injection in pre-filled pen Ireland - English - HPRA (Health Products Regulatory Authority)

norditropin nordiflex 5 mg/1.5 ml solution for injection in pre-filled pen

novo nordisk a/s - somatropin - solution for injection in pre-filled pen - 5mg/1.5ml micromole(s) - somatropin and somatropin agonists; somatropin

Norditropin SimpleXx 5 mg/1.5 ml, solution for injection in cartridge Ireland - English - HPRA (Health Products Regulatory Authority)

norditropin simplexx 5 mg/1.5 ml, solution for injection in cartridge

novo nordisk a/s - somatropin - solution for injection in cartridge - 5mg/1.5ml - somatropin and somatropin agonists; somatropin

Norditropin SimpleXx 15 mg/1.5 ml, solution for injection in cartridge Ireland - English - HPRA (Health Products Regulatory Authority)

norditropin simplexx 15 mg/1.5 ml, solution for injection in cartridge

novo nordisk a/s - somatropin - solution for injection in cartridge - 15mg/1.5ml - somatropin and somatropin agonists; somatropin

Norditropin SimpleXx 10 mg/1.5 ml, solution for injection in cartridge Ireland - English - HPRA (Health Products Regulatory Authority)

norditropin simplexx 10 mg/1.5 ml, solution for injection in cartridge

novo nordisk a/s - somatropin - solution for injection in cartridge - 10mg/1.5ml - somatropin and somatropin agonists; somatropin

NORDITROPIN- somatropin injection, solution United States - English - NLM (National Library of Medicine)

norditropin- somatropin injection, solution

novo nordisk - somatropin (unii: nqx9kb6pcl) (somatropin - unii:nqx9kb6pcl) - somatropin 5 mg in 1.5 ml - norditropin is indicated for the treatment of pediatric patients with: norditropin is indicated for the replacement of endogenous gh in adults with growth hormone deficiency (ghd) norditropin is contraindicated in patients with: risk summary limited available data with somatropin use in pregnant women are insufficient to determine a drug-associated risk of adverse developmental outcomes. in animal reproduction studies, there was no evidence of fetal or neonatal harm when pregnant rats were administered subcutaneous norditropin during organogenesis or during lactation at doses approximately 10-times higher than the maximal clinical dose of 0.016 mg/kg, based on body surface area (see data). the estimated background risk of birth defects and miscarriage for the indicated population is unknown. in the u.s. general population, the estimated background risk of major birth defects and miscarriage in clinically recognized pregnancies is 2-4% and 15-20%, respectively. data animal data in an embryo-fetal development s

Norditropin NordiFlex 10 mg/1.5 ml solution for injection in pre-filled pen Ireland - English - HPRA (Health Products Regulatory Authority)

norditropin nordiflex 10 mg/1.5 ml solution for injection in pre-filled pen

pco manufacturing ltd. - somatropin - solution for injection in pre-filled pen - somatropin and somatropin agonists; somatropin

SAIZEN somatropin (rmc) 20mg/2.5mL solution for injection multidose cartridge Australia - English - Department of Health (Therapeutic Goods Administration)

saizen somatropin (rmc) 20mg/2.5ml solution for injection multidose cartridge

merck healthcare pty ltd - somatropin, quantity: 8 mg/ml - injection, solution - excipient ingredients: phenol; sucrose; citric acid; poloxamer; water for injections; sodium hydroxide - saizen is indicated for:,1. treatment of growth failure in children due to human growth hormone deficiency.,2. treatment of growth failure in girls with gonadal dysgenesis (turner syndrome), confirmed by chromosomal analysis.,3. replacement therapy in adults with pronounced growth hormone deficiency as diagnosed in 2 different dynamic tests for growth hormone deficiency and defind by peak gh concentrations of less than 2.5 nanogram/ml. adults must also fulfill the following criteria: childhood onset: patients who were diagnosed as growth hormone deficient during childhood, must be retested and their growth hormone deficiency confirmed before replacement therapy with saizen is started. adult onset: patients must have growth hormone deficiency as a result of hypothalamic or pituitary disease and at least one other hormone deficiency diagnosed (except for prolactin) and adequate replacement therapy instituted, before replacement therapy using growth hormone may begin.,4. treatment of growth disturbance (growth retardation) in pre-pubertal children due to chronic renal insufficiency (cri).